Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11464 posts found.

Maze Therapeutics and Sanofi sign exclusive worldwide license agreement for Pompe disease treatment

May 3, 2023 Sales and Marketing License Agreement, Pompe disease, Rare Diseases, Sanofi, maze therapeutics, treatment

Maze Therapeutics and Sanofi have announced that they have signed an exclusive worldwide license agreement for Maze’s gluogen synthase 1 …
News
cdc-d5nff1slguy-unsplash

FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children

April 28, 2023 Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine

Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …
News
christina-victoria-craft-zhys6xn7sue-unsplash_5

PANTHERx Rare announces release of treatment for rare stable Wilson Disease

April 20, 2023 Sales and Marketing

US-based rare medicines pharmacy PANTHERx Rare has announced the launch of Cuvrior, a treatment for stable Wilson Disease in adults …
News
milad-fakurian-58z17lnvs4u-unsplash_2

Acadia Pharmaceuticals announces commercialisation of Daybue for Rett syndrome

April 19, 2023 Sales and Marketing

Acadia Pharmaceuticals has announced that Daybue (trofinetide) is now available for adult and paediatric patients over the age of two …
News

Ariceum Therapeutics announces extension of Series A financing for radiopharmaceutical clinical pipeline

April 18, 2023 Sales and Marketing

Private biotech company Ariceum Therapeutics has announced the successful completion of Series A extension financing, raising an additional €22.75m following …
News
volodymyr-hryshchenko-m1hq4ibp9rc-unsplash

Merck acquires Prometheus Biosciences, strengthens immunology pipeline

April 17, 2023 Sales and Marketing

Merck (known as MSD outside of the US and Canada) has announced that it, through a subsidiary, has agreed to …
News
mark-paton-bmzkw_nn0pq-unsplash

Neuromod closes €30m financing for new tinnitus treatment device

April 14, 2023 Sales and Marketing

Irish medical device company Neuromod has announced that it has successfully closed a €30m financing intended to further commercialise Lenire, …
News

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 13, 2023 Sales and Marketing

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …
News
Press release

Alentis Therapeutics closes $105m Series C funding for new treatment options

April 13, 2023 Sales and Marketing

Alentis Therapeutics has announced $105m in Series C funding which was led by Jeito Capital together with Novo Holdings A/S …
News
christina-victoria-craft-whsnkiwwpec-unsplash_4

ImaginAb signs new license and supply agreement with Leucid Bio for CD8 ImmunoPET technology

April 12, 2023 Sales and Marketing

Biotechnology company ImaginAb has announced that it has signed a new non-exclusive License and Supply Agreement (LSA) with Leucid Bio. …
News

Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101

April 3, 2023 Sales and Marketing

Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …
News

Alzheimer’s drug Leqembi expected to generate $12.9bn in sales by 2028

March 30, 2023 Sales and Marketing

After receiving FDA approval in January 2023, Biogen/Eisai’s new Alzheimer’s disease Leqembi is expected to become a blockbuster, with a …
News

PureTech Health and Royalty Pharma enter KarXT royalty agreement up to $500m

March 23, 2023 Sales and Marketing

Royalty Pharma have acquired a $500m interest in PureTech’s royalty in Karuna Therapeutics’ KarXT, with $100m cash up front and …
News

BioNTech and OncoC4 to partner for development and commercialisation of novel checkpoint antibody

March 21, 2023 Sales and Marketing

BioNTech and OncoC4 have entered a strategic collaboration for the co-development and commercialisation of a novel checkpoint antibody for multiple …
News

Sun Pharma settles at $75m in industry-wide price-fixing case

March 17, 2023 Sales and Marketing

Sun Pharma has decided a settlement of $75m as part of a case surrounding various pharma companies fixing their prices. …
News

Latest content

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023